SLNO - Soleno Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SLNO is currently covered by 8 analysts with an average price target of $122.52. This is a potential upside of $37.65 (44.36%) from yesterday's end of day stock price of $84.87.

Soleno Therapeutics's activity chart (see below) currently has 9 price targets and 46 ratings on display. The stock rating distribution of SLNO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 61.63% with an average time for these price targets to be met of 130.63 days.

Highest price target for SLNO is $145, Lowest price target is $73, average price target is $104.75.

Most recent stock forecast was given by BRIAN SKORNEY from BAIRD on 11-Jul-2025. First documented stock forecast 22-Jun-2018.

Currently out of the existing stock ratings of SLNO, 37 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$121

$34.53 (39.93%)

$105

20 days ago
(11-Jul-2025)

2/5 (40%)

$39.43 (48.34%)

224

Buy

$97

$10.53 (12.18%)

$81

2 months 23 days ago
(08-May-2025)

3/4 (75%)

$20.74 (27.20%)

50

Buy

$145

$58.53 (67.69%)

$93

3 months 7 days ago
(24-Apr-2025)

0/3 (0%)

$70.77 (95.34%)

Buy

$100

$13.53 (15.65%)

$100

3 months 16 days ago
(15-Apr-2025)

4/6 (66.67%)

$29.75 (42.35%)

121

Buy

$123

$36.53 (42.25%)

$67

4 months 4 days ago
(27-Mar-2025)

6/7 (85.71%)

$55.61 (82.52%)

111

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SLNO (Soleno Therapeutics) average time for price targets to be met?

On average it took 130.63 days on average for the stock forecasts to be realized with a an average price target met ratio 61.63

Which analyst has the current highest performing score on SLNO (Soleno Therapeutics) with a proven track record?

BRIAN SKORNEY

Which analyst has the current lower performing score on SLNO (Soleno Therapeutics) with a proven track record?

YASMEEN RAHIMI

Which analyst has the most public recommendations on SLNO (Soleno Therapeutics)?

Brian Skorney works at BAIRD and has 9 price targets and 5 ratings on SLNO

Which analyst is the currently most bullish on SLNO (Soleno Therapeutics)?

Yasmeen Rahimi with highest potential upside - $58.53

Which analyst is the currently most reserved on SLNO (Soleno Therapeutics)?

Leland Gershell with lowest potential downside - -$13.47

Soleno Therapeutics in the News

Soleno Therapeutics stock price target raised to $115 from $108 at Stifel

Investing.com – Stifel raised its price target on Soleno Therapeutics Inc. (NASDAQ:SLNO) to $115.00 from $108.00 on Monday, while maintaining a Buy rating on the stock. The company, currently valued at $4.28 billion, has seen its stock surge over 111% in the past year, according to InvestingPro data. The price target increase follows a survey...

Soleno Therapeutics Announces Oral Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ESPE and ESE 2025

Soleno Therapeutics REDWOOD CITY, Calif., May 08, 2025 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will present data from its VYKATTM XR (diazoxide choline) extended-release tablets, previously referred to as DCCR, clinical development program for the treatment...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?